KARLIN DANIEL (Chief Medical Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2026ACC: 0001193125-26-389892
Officer· Chief Medical Officer
Since Jan 2022
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
33.1%
9/14/2026
603.70K→803.70K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/14/2026 | A · Award | +200K | — | — | 33.1% | 603.70K | 803.70K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported